Guanhao Biotech Co Ltd - ESG Rating & Company Profile powered by AI
The page contains a Q&A section for Guanhao Biotech Co Ltd. The page displays a free Environmental, Social and Governance assessment for Guanhao Biotech Co Ltd. The Sustainability rating for Guanhao Biotech Co Ltd indicates the company's transparency towards the UN SDGs.
Guanhao Biotech Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Guanhao Biotech Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Guanhao Biotech Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Guanhao Biotech Co Ltd disclose current and historical energy intensity?
Does Guanhao Biotech Co Ltd report the average age of the workforce?
Does Guanhao Biotech Co Ltd reference operational or capital allocation in relation to climate change?
Does Guanhao Biotech Co Ltd disclose its ethnicity pay gap?
Does Guanhao Biotech Co Ltd disclose cybersecurity risks?
Does Guanhao Biotech Co Ltd offer flexible work?
Does Guanhao Biotech Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Guanhao Biotech Co Ltd disclose the number of employees in R&D functions?
Does Guanhao Biotech Co Ltd conduct supply chain audits?
Does Guanhao Biotech Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Guanhao Biotech Co Ltd conduct 360 degree staff reviews?
Does Guanhao Biotech Co Ltd disclose the individual responsible for D&I?
Does Guanhao Biotech Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Guanhao Biotech Co Ltd disclose current and / or historical scope 2 emissions?
Does Guanhao Biotech Co Ltd disclose water use targets?
Does Guanhao Biotech Co Ltd have careers partnerships with academic institutions?
Did Guanhao Biotech Co Ltd have a product recall in the last two years?
Does Guanhao Biotech Co Ltd disclose incidents of discrimination?
Does Guanhao Biotech Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Guanhao Biotech Co Ltd issued a profit warning in the past 24 months?
Does Guanhao Biotech Co Ltd disclose parental leave metrics?
Does Guanhao Biotech Co Ltd disclose climate scenario or pathway analysis?
Does Guanhao Biotech Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Guanhao Biotech Co Ltd disclose the pay ratio of women to men?
Does Guanhao Biotech Co Ltd support suppliers with sustainability related research and development?
Does Guanhao Biotech Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Guanhao Biotech Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Guanhao Biotech Co Ltd involved in embryonic stem cell research?
Does Guanhao Biotech Co Ltd disclose GHG and Air Emissions intensity?
Does Guanhao Biotech Co Ltd disclose its waste policy?
Does Guanhao Biotech Co Ltd report according to TCFD requirements?
Does Guanhao Biotech Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Guanhao Biotech Co Ltd disclose energy use targets?
Does Guanhao Biotech Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Guanhao Biotech Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Guanhao Biotech Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Guanhao Biotech Co.,Ltd. develops, manufactures, and markets regenerative medicine in China. It offers NormalGEN, a type of biological dura repair patch manufactured from animal tissue; GrandNeuro, an artificial dura patch for dura repairing; ThormalGEN, a biological surgical patch manufactured from animal tissue for surgical repairs; DermalGEN, a wound dressing product manufactured from animal tissue for use on burns, scalds, and wounds due to skin loss or trauma; and IREAL breast patch. The company was founded in 1999 and is based in Guangzhou, China.